BNET Industries

Blood Diagnostics Inc.

is in the Pharma Industry

Last Fiscal Year Sales:$17.5M
  • Private
  • US
Dow Jones Description

Serving the healthcare community since 1995, BDI Pharma, Inc. (formerly Blood Diagnostics, Inc.), is one of the nation's premier wholesale distributors of specialty biopharmaceuticals. Our market focus is evident in our commitment to specialty biotherapeutics, immunologics, hemostatics and oncologics. Products under these categories include IVIG / IGIV, albumin and PPF, coagulation factors, hyper-immune globulins, vaccines, chemotherapies and other physician specialty pharmaceuticals. We are an Authorized Distributor of Record (ADR) for all of the products we supply and we meet all accreditation, insurance and licensing requirements for all 50 states. BDI employs the most courteous, ethical and knowledgeable representatives in the industry and we are available 24 hours a day, 7 days a week to ship product from both the East and West Coast.

President and Co-Founder
Richard Gaton
Number of Employees 34
Contact Information

120 Research Dr

Columbia, South Carolina 29203

www.blooddiagno...

NAICS Code Drugs and Druggists' Sundries Merchant Wholesalers: 424210

News & Analysis

blood diagnostics inc. - All News and Analysis

  • Blood Diagnostics, Inc. Becomes BDI Pharma, Inc.

    - 2009-02-02

    Blood Diagnostics, Inc., a national leader in the distribution of biopharmaceutical products, announced that effective February 1, 2009 the company will begin operations from its new corporate headquarters under the corporation's new name -- BDI Pharma, Inc. The company will remain independent with the same ownership as it has for...

    Tags: Blood Diagnostics Inc.

  • BDI (Blood Diagnostics, Inc.) Announces Record Q3 Revenue Growth

    - 2008-10-02

    BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the third quarter of 2008 rose thirty-seven percent (37%) in comparison to the same time period in 2007. The current rate of sales represents revenue growth pacing in excess of twenty-six percent (26%) over last year....

    Tags: Blood Diagnostics Inc.

  • BDI (Blood Diagnostics, Inc.) Announces Continued Growth Through Q2

    - 2008-07-17

    BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the first two quarters of 2008 continued to demonstrate an increase of more than twenty percent (20%) in comparison to same time period in 2007. With a history of strong third and fourth quarter sales,...

    Tags: Blood Diagnostics Inc.

  • Blood Diagnostics, Inc. Awarded MedAssets Supply Chain Systems' Platinum Vendor Designation

    - 2008-05-19

    Blood Diagnostics, Inc. BDI today announced it recently earned MedAssets Supply Chain Systems' Platinum Vendor status. The platinum level is the highest vendor designation awarded by MedAssets Supply Chain Systems, a MedAssets company (NASDAQ: MDAS). Blood Diagnostics, Inc. was awarded the Platinum Vendor designation at the MedAssets Healthcare Business Summit...

    Tags: MedAssets Inc.

  • Blood Diagnostics, Inc. (BDI) Announces First Quarter Growth

    - 2008-04-25

    Blood Diagnostics, Inc. BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the first quarter of 2008 represented a twenty-seven percent (27%) increase in comparison to Q1 2007. This pace is ahead of the company's average rate of growth for the preceding three fiscal...

    Tags: Blood Diagnostics Inc.

Decision Makers

Name (plus bio) Position
Richard Gaton President and Co-Founder

Organization Position Status
Blood Diagnostics, Inc President and Co-Founder Current
Blood Diagnostics, Inc Owner Current

Executive News

  • BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Continues Growth Regardless of Market Volatility

    BioSpace - 8/11/09 - View Story